Agios Pharmaceuticals Drives Cancer Treatment with Metabolism‑Focused Breakthroughs
Agios Pharmaceuticals leads biotech with cancer‑metabolism drugs targeting glycolysis, fatty acid metabolism and autophagy, driving precision therapy and strong market growth.
2 minutes to read
